<h3>Background</h3> Neutrophil extracellular traps (NETs), released from activated neutrophils, have been implicated in contributing to micro- and macro-vascular thrombosis. The major structural component of NETs is nucleosomes, which consists of DNA wrapped around a core histone octamer containing two copies each of histone H2A, H2B, H3, and H4. The release of NETs occurs via a unique cell death pathway (termed NETosis), which requires the decondensation of chromatin by PAD4. PAD4 is a nuclear enzyme that converts specific arginine residues to citrulline on histones, thereby reducing the positive charge of histones. DNA activates the intrinsic pathway of coagulation and impairs fibrinolysis, whereas histones activate platelets and are cytotoxic to vascular endothelial cells. In purified systems, DNA-histone complexes are resistant to digestion by DNaseI. The addition of unfractionated heparin (UFH) displaces the DNA-histone complex, thereby rendering DNA susceptible to digestion by DNaseI. <h3>Objectives</h3> The objective of this study is to examine the effects of various glycosaminoglycans (GAGs), including UFH (15kDa), Enoxaparin (4.5kDa), and Fondaparinux (1.7kDa) on DNaseI-mediated digestion of DNA-protein complexes as well as NETs released by activated neutrophils. <h3>Methods</h3> Genomic DNA was isolated from human leukocytes and incubated with a mixture of bovine histones. The DNA protein complexes were treated with recombinant human DNaseI (Pulmozyme) in the absence or presence of GAGs and visualized using agarose gel electrophoresis. To produce NETs, neutrophils from healthy volunteers were added to glass coverslips and stimulated with PMA for 4 hours. The NETs were then treated with DNaseI in the absence or presence of GAGs and visualized using fluorescence microscopy. The binding affinities between the different GAGs and histones were determined by Bio-layer Interferometry (BLItz instrument). <h3>Results</h3> DNaseI alone was unable to degrade DNA-histone complexes. The addition of UFH or Enoxaparin rendered the complexes susceptible to complete digestion by DNaseI, whereas Fondaparinux did not. Next, we measured the binding affinities between the GAGs and individual histones. We found that UFH and Enoxaparin bind histones H2A, H2B, H3, and H4 with high affinities (KD values ranging from 1 pM to 6.2 nM), which supports the model that these GAGs can displace histones from DNA-histone complexes. With respect to NETs released by activated neutrophils, DNaseI alone was able to completely digest the DNA component of NETs even in the absence of GAGs. <h3>Conclusions</h3> Our studies suggest that GAGs displace DNA-histone complexes, thereby rendering DNA susceptible to degradation by DNaseI. The inability of Fondaparinux to displace the DNA-histone complexes suggests that the GAG cofactor activity is size-dependent. In contrast, DNaseI is able to degrade DNA within NETs without a requirement for GAGs. The ability of DNaseI to degrade DNA within NETs may be due to histone citrullination that occurs during NETosis, a process that weakens DNA-histone interactions.